This edition of Pharmacy Pearls is to assist with challenges faced in clinical practice managing migraineurs and with the approval of new agents to help prevent migraine. AHP assembled a…
This edition of Pharmacy Pearls is to assist with challenges faced in clinical practice managing migraineurs and with the approval of new agents to help prevent migraine. AHP assembled a…
135 Corporate Woods, Suite 320
Rochester, New York 14623-1466
Phone: (585) 758-7823
Fax: (585) 424-1268
This is not an offer to purchase or a solicitation of an offer to purchase any securities or interest in Accountable Health Partners, LLC (AHP). An offer will only be made by means of a confidential private placement memorandum and subscription agreement.
ABI Value | Interpretation | Recommendation |
---|---|---|
Greater than 1.4 | Calcification/vessel hardening | Refer to vascular specialist |
1.0 - 1.4 | Normal | None |
0.9 - 1.0 | Acceptable | None |
0.8 - 0.9 | Some arterial disease | Treat risk factor |
0.5 - 0.8 | Moderate arterial disease | Refer to vascular specialist |
Less than 0.5 | Severe arterial disease | Refer to vascular specialist |
Medicare/Medicare HMO patient must be homebound (trouble leaving home without help [e.g., using a cane, wheelchair, walker, or crutches]; needing special transportation; or requiring help from another person) because of an illness or injury, or leaving home isn't recommended because of condition, normally unable to leave home because it's a major effort